afatinib 30 MG Oral Tablet

RxCUI: 1430451
RxNorm name: afatinib 30 MG Oral Tablet
Display name: afatinib 30 MG Oral Tablet
Full name: afatinib 30 MG Oral Tablet
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:29

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Gilotrif	AFATINIB	Boehringer Ingelheim Pharmaceuticals, Inc.	fd638e5e-8032-e7ca-0179-95e96ab5d387	2025-11-13	Warnings, Adverse reactions	Exact identifier rxcui: 1430451

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
fd638e5e-8032-e7ca-0179-95e96ab5d387	afatinib 30 MG Oral Tablet	PSN	20	These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. GILOTRIF ® (afatinib tablets), for oral use Initial U.S. Approval: 2013	20251113
fd638e5e-8032-e7ca-0179-95e96ab5d387	afatinib 30 MG Oral Tablet	SCD	20	These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. GILOTRIF ® (afatinib tablets), for oral use Initial U.S. Approval: 2013	20251113
fd638e5e-8032-e7ca-0179-95e96ab5d387	afatinib 30 MG (as afatinib dimaleate 44.34 MG) Oral Tablet	SY	20	These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. GILOTRIF ® (afatinib tablets), for oral use Initial U.S. Approval: 2013	20251113